Alpha Teknova (Alpha Teknova) Growth Rank : 0 (As of May. 18, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Teknova Growth Rank?

Alpha Teknova has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Alpha Teknova Growth Rank Related Terms

Thank you for viewing the detailed overview of Alpha Teknova's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Teknova (Alpha Teknova) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpha Teknova Inc (NAS:TKNO) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2451 Bert Drive, Hollister, CA, USA, 95023

Website

https://www.teknova.com

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Executives

Ken Gelhaus	officer: Chief Commercial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Stephen Gunstream	director, officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
J Matthew Mackowski	director	343 SANSOME ST, SUITE 1215, SANSASAN FRANCISCO CA 94104
Matthew Lowell	officer: Chief Financial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Damon Terrill	officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
Thp Iv Affiliates Fund, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Lisa Hood	officer: Chief People Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Irene Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Ted Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Iv, L.p.	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO MA 94108
Paul David Grossman	director	1600 FARADAY AVENUE, CARLSBAD CA 92008
Brett Robertson	director	C/O INVUITY, INC., 444 DE HARO STREET, SAN FRANCOSCO CA 94107
Alexander C. Herzick	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Management Company, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108